Moxetumomab pasudotox and Urokinase Intravenous
Determining the interaction of Moxetumomab pasudotox and Urokinase Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: urokinase
Brand name: Kinlytic, Abbokinase, Abbokinase Open-Cath
Synonyms: Urokinase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Urolet MB
- Moxetumomab pasudotox-Urophen MB
- Moxetumomab pasudotox-Uroxatral
- Moxetumomab pasudotox-Urso
- Moxetumomab pasudotox-Urso 250
- Moxetumomab pasudotox-Urso Forte
- Urokinase Intravenous-Moxetumomab Pasudotox-tdfk
- Urokinase Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Urokinase Intravenous-Moxifloxacin
- Urokinase Intravenous-Moxifloxacin (Systemic)
- Urokinase Intravenous-Moxifloxacin Hydrochloride
- Urokinase Intravenous-Moxifloxacin Injection